Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
WorldConference

2nd Antigen-Specific Immune Tolerance Summit 2019

Join your peers and become central to leading industry conversations dedicated to overcoming the challenge of discovering and defining monogenic and multigenic antigens.

Add this event to your calendar: iCal   Google Calendar

Who should attend?

Open to all

Details

As the race to generate compelling clinical data to prove the concept of antigen-specific immunotherapies gains momentum, the 2nd Antigen-Specific Immune Tolerance Drug Development Summit returns to Boston in 2019 to help large pharma, biotech, and academic researchers to overcome the complexity of auto-immune mediated disorders, expand opportunities through combination strategies and undertake a more precise and antigen-specific approach to novel drug development.

KEY Features of the 2nd Antigen-Specific Immune Tolerance Drug Development Summit:

World-Class Speaker Faculty from the Likes of GSK, Eli Lilly, ITN and FDA
Curated Learning Journey from Early Discovery to Clinical Development
An Impactful 3-Day Summit with Solution Led Case Studies from the Fields of Allergy and Autoimmunity
Deep-Dive into the Crucial Challenges and Critical Decision Making to Successfully Translate Promising Strategies into Effective Therapies
Critical Strategic Discussions Focused On Expanding Opportunities Through Combination Therapies to Address Unmet Clinical Needs
Intimate Networking with Key Decision-Makers from large Pharma, Biotech and Academia Through High-Quality Discussions

"This meeting will provide opportunities to network with key scientists, hear about the latest developments and state-of-the-art science in the field of immune tolerance"
Antoon Van Oosterhout
VP and Head Allergic Inflammation Discovery Performance Unit
GSK

"I look forward to participating at this summit as cross-disease and cross-discipline exchanges are critical if we are to make disease- modifying therapy a reality in type 1 diabetes"
Carla Greenbaum
Director- Diabetes Program
Benaroya Research Institute

Prices

Conference + 3 Workshops Before December 14, 2018 (Drug Developers): USD 3299.0, Conference + 3 Workshops Standard Price (Drug Developers): USD 4099.0, Conference + 2 Workshops Before December 14, 2018 (Drug Developers): USD 2999.0, Conference + 2 Workshops Standard Price (Drug Developers): USD 3799.0, Conference + 1 Workshop Before December 14, 2018 (Drug Developers): USD 2599.0, Conference + 1 Workshop Standard Price (Drug Developers): USD 3399.0, Conference Only Before December 14, 2018 (Drug Developers): USD 2099.0, Conference Only Standard Price (Drug Developers): USD 2899.0, Conference + 3 Workshops Before December 14, 2018 (Academics): USD 2199.0, Conference + 3 Workshops Standard Price (Academics): USD 2799.0

Contact

Shima Salmasi
info@hansonwade.com

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.